150 results on '"Ben Yakov, Gil"'
Search Results
2. A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
3. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease
4. XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
5. Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients.
6. Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
7. Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years
8. The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
9. Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients
10. Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
11. Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study
12. Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management
13. Stimulating More Than Just the Granulocytes: Drug-Induced Liver Injury From Filgrastim
14. Time to Publication for Randomized Clinical Trials Presented as Abstracts at Three Gastroenterology and Hepatology Conferences in 2017
15. Research trends analysis of chronic hepatitis C versus nonalcoholic fatty liver disease: A literature review text‐mining analysis of publications
16. Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients
17. A Misleading Pattern of Serologic Findings During Hepatitis B Virus Infection
18. Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity
19. HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
20. The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort
21. Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients
22. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel
23. Cryptosporidium infection in dedicator of cytokinesis 8 (DOCK 8) deficiency
24. Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
25. One world, one pandemic, many guidelines: management of liver diseases during COVID-19
26. Su1654 PRIMARY SCLEROSING CHOLANGITIS, STABLE IN INCIDENCE EXCEEDING IN COST - 10- YEAR US PERSPECTIVE OF TRENDS IN PSC HOSPITALIZATION CHARACTERISTICS
27. Spontaneous Clearance of Chronic Delta Hepatitis
28. Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
29. Liver disturbances in activated phosphoinositide 3-kinase δ syndrome
30. Facing the challenge - Providing liver care at times of pandemic
31. Inclusion of Clinical Trial Registration Numbers in Conference Abstracts and Conformance of Abstracts to CONSORT Guidelines
32. Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard?
33. 504 – Liver Involvment in Dedicator of Cytokine 8 (DOCK 8) Deficiancy Syndrome – Report from a Single Center Cohort
34. 407 – The Delta-4 Score: A Novel and Clinically Useful Noninvasive Fibrosis Score for Hepatitis D
35. The Spectrum of Hepatic Involvement in Patients With Telomere Disease
36. Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease.
37. Roadmap to resuming care for liver diseases after coronavirus disease‐2019.
38. Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Cross-Sectional Study of 3,207 Patients
39. Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma
40. Innumerable Liver Lesions With a More Benign Outcome: A Case Report
41. Starry Night on Liver MRI: An Unexpected Incidental Finding in a Healthy Recruit
42. Mo1491 - Fibroscan in Sickle Cell Liver Disease-Could we Strike while the Liver is Hard?
43. Tu1539 - Vibration Controlled Elastography Predicts Severity of Portal Hypertension in Non Cirrhotic Portal Hypertension
44. Su1551 - Low Skeletal Muscle Mass is Associated with Advanced Steatosis in Non Alcoholic Fatty Liver Disease
45. Tu1570 - Inflammatory Cytokines, not Disease Severity, may Provide Biological Insights into Poor Sleep Quality in Chronic Hepatitis B and C Infections
46. Sa1486 - Modeling Histologic and Biochemical Improvements of Disease Severity in Chronic Hepatitis B Patients Treated with Long Term Nucleoside Analogues for Up to 18 Years and the Utility of Non-Invasive Biomarkers
47. XCR1+type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
48. Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial
49. Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma.
50. Liver disturbances in activated phosphoinositide 3-kinase δ syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.